The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Emphysema Treatment Medication Market Research Report 2025
Synopsis
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
The global Emphysema Treatment Medication market was valued at US$ 4125 million in 2023 and is anticipated to reach US$ 5178 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Surge in prevalence of emphysema and rise in number of smokers are expected to drive the growth of the emphysema treatment market. For instance, according to 2024 article by American Lung Association, it was estimated that over 3 million people in the U.S. have been diagnosed with emphysema. Furthermore, according to a report by Foundation for a Smoke-Free World, it was reported that prevalence of smoking in India was estimated to be 4.6%.
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment Medication.
The Emphysema Treatment Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Emphysema Treatment Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Emphysema Treatment Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emphasys Medical
Pfizer
Uptake Medical
Inogen, Inc
Viatris Inc
Boehringer Ingelheim International GmbH
Novartis AG
AstraZeneca
Orion Corporation
Teva Pharmaceutical Industries Ltd
Verona Pharma Plc
GlaxoSmithKline Plc
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Segment by Type
Bronchodilators
Steroids
Others
Segment by Application
Hospitals
Homecare
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emphysema Treatment Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Emphysema is a chronic and progressive lung condition characterized by damage to the air sacs in the lungs, known as alveoli. This damage leads to the deterioration of the lung tissue and results in decreased elasticity, making it difficult to breathe. The primary cause of emphysema is long-term exposure to irritants, most commonly cigarette smoke, although other factors such as air pollution and genetic predisposition can also contribute. Symptoms of emphysema include shortness of breath, chronic coughing, wheezing, and tightness in the chest. Treatment for emphysema focuses on managing symptoms and slowing down the progression of the disease. Medication is the therapeutic interventions for emphysema treatment.
The global Emphysema Treatment Medication market was valued at US$ 4125 million in 2023 and is anticipated to reach US$ 5178 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Surge in prevalence of emphysema and rise in number of smokers are expected to drive the growth of the emphysema treatment market. For instance, according to 2024 article by American Lung Association, it was estimated that over 3 million people in the U.S. have been diagnosed with emphysema. Furthermore, according to a report by Foundation for a Smoke-Free World, it was reported that prevalence of smoking in India was estimated to be 4.6%.
This report aims to provide a comprehensive presentation of the global market for Emphysema Treatment Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Treatment Medication.
The Emphysema Treatment Medication market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Emphysema Treatment Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Emphysema Treatment Medication companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Emphasys Medical
Pfizer
Uptake Medical
Inogen, Inc
Viatris Inc
Boehringer Ingelheim International GmbH
Novartis AG
AstraZeneca
Orion Corporation
Teva Pharmaceutical Industries Ltd
Verona Pharma Plc
GlaxoSmithKline Plc
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Segment by Type
Bronchodilators
Steroids
Others
Segment by Application
Hospitals
Homecare
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Emphysema Treatment Medication company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Emphysema Treatment Medication Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bronchodilators
1.2.3 Steroids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Emphysema Treatment Medication Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Emphysema Treatment Medication Market Perspective (2019-2030)
2.2 Global Emphysema Treatment Medication Growth Trends by Region
2.2.1 Global Emphysema Treatment Medication Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Emphysema Treatment Medication Historic Market Size by Region (2019-2024)
2.2.3 Emphysema Treatment Medication Forecasted Market Size by Region (2025-2030)
2.3 Emphysema Treatment Medication Market Dynamics
2.3.1 Emphysema Treatment Medication Industry Trends
2.3.2 Emphysema Treatment Medication Market Drivers
2.3.3 Emphysema Treatment Medication Market Challenges
2.3.4 Emphysema Treatment Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Emphysema Treatment Medication Players by Revenue
3.1.1 Global Top Emphysema Treatment Medication Players by Revenue (2019-2024)
3.1.2 Global Emphysema Treatment Medication Revenue Market Share by Players (2019-2024)
3.2 Global Emphysema Treatment Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Emphysema Treatment Medication Revenue
3.4 Global Emphysema Treatment Medication Market Concentration Ratio
3.4.1 Global Emphysema Treatment Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Emphysema Treatment Medication Revenue in 2023
3.5 Global Key Players of Emphysema Treatment Medication Head office and Area Served
3.6 Global Key Players of Emphysema Treatment Medication, Product and Application
3.7 Global Key Players of Emphysema Treatment Medication, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Emphysema Treatment Medication Breakdown Data by Type
4.1 Global Emphysema Treatment Medication Historic Market Size by Type (2019-2024)
4.2 Global Emphysema Treatment Medication Forecasted Market Size by Type (2025-2030)
5 Emphysema Treatment Medication Breakdown Data by Application
5.1 Global Emphysema Treatment Medication Historic Market Size by Application (2019-2024)
5.2 Global Emphysema Treatment Medication Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Emphysema Treatment Medication Market Size (2019-2030)
6.2 North America Emphysema Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Emphysema Treatment Medication Market Size by Country (2019-2024)
6.4 North America Emphysema Treatment Medication Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Emphysema Treatment Medication Market Size (2019-2030)
7.2 Europe Emphysema Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Emphysema Treatment Medication Market Size by Country (2019-2024)
7.4 Europe Emphysema Treatment Medication Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Emphysema Treatment Medication Market Size (2019-2030)
8.2 Asia-Pacific Emphysema Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Emphysema Treatment Medication Market Size by Region (2019-2024)
8.4 Asia-Pacific Emphysema Treatment Medication Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Emphysema Treatment Medication Market Size (2019-2030)
9.2 Latin America Emphysema Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Emphysema Treatment Medication Market Size by Country (2019-2024)
9.4 Latin America Emphysema Treatment Medication Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Emphysema Treatment Medication Market Size (2019-2030)
10.2 Middle East & Africa Emphysema Treatment Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Emphysema Treatment Medication Market Size by Country (2019-2024)
10.4 Middle East & Africa Emphysema Treatment Medication Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emphasys Medical
11.1.1 Emphasys Medical Company Details
11.1.2 Emphasys Medical Business Overview
11.1.3 Emphasys Medical Emphysema Treatment Medication Introduction
11.1.4 Emphasys Medical Revenue in Emphysema Treatment Medication Business (2019-2024)
11.1.5 Emphasys Medical Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Emphysema Treatment Medication Introduction
11.2.4 Pfizer Revenue in Emphysema Treatment Medication Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Uptake Medical
11.3.1 Uptake Medical Company Details
11.3.2 Uptake Medical Business Overview
11.3.3 Uptake Medical Emphysema Treatment Medication Introduction
11.3.4 Uptake Medical Revenue in Emphysema Treatment Medication Business (2019-2024)
11.3.5 Uptake Medical Recent Development
11.4 Inogen, Inc
11.4.1 Inogen, Inc Company Details
11.4.2 Inogen, Inc Business Overview
11.4.3 Inogen, Inc Emphysema Treatment Medication Introduction
11.4.4 Inogen, Inc Revenue in Emphysema Treatment Medication Business (2019-2024)
11.4.5 Inogen, Inc Recent Development
11.5 Viatris Inc
11.5.1 Viatris Inc Company Details
11.5.2 Viatris Inc Business Overview
11.5.3 Viatris Inc Emphysema Treatment Medication Introduction
11.5.4 Viatris Inc Revenue in Emphysema Treatment Medication Business (2019-2024)
11.5.5 Viatris Inc Recent Development
11.6 Boehringer Ingelheim International GmbH
11.6.1 Boehringer Ingelheim International GmbH Company Details
11.6.2 Boehringer Ingelheim International GmbH Business Overview
11.6.3 Boehringer Ingelheim International GmbH Emphysema Treatment Medication Introduction
11.6.4 Boehringer Ingelheim International GmbH Revenue in Emphysema Treatment Medication Business (2019-2024)
11.6.5 Boehringer Ingelheim International GmbH Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Emphysema Treatment Medication Introduction
11.7.4 Novartis AG Revenue in Emphysema Treatment Medication Business (2019-2024)
11.7.5 Novartis AG Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Emphysema Treatment Medication Introduction
11.8.4 AstraZeneca Revenue in Emphysema Treatment Medication Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Orion Corporation
11.9.1 Orion Corporation Company Details
11.9.2 Orion Corporation Business Overview
11.9.3 Orion Corporation Emphysema Treatment Medication Introduction
11.9.4 Orion Corporation Revenue in Emphysema Treatment Medication Business (2019-2024)
11.9.5 Orion Corporation Recent Development
11.10 Teva Pharmaceutical Industries Ltd
11.10.1 Teva Pharmaceutical Industries Ltd Company Details
11.10.2 Teva Pharmaceutical Industries Ltd Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Introduction
11.10.4 Teva Pharmaceutical Industries Ltd Revenue in Emphysema Treatment Medication Business (2019-2024)
11.10.5 Teva Pharmaceutical Industries Ltd Recent Development
11.11 Verona Pharma Plc
11.11.1 Verona Pharma Plc Company Details
11.11.2 Verona Pharma Plc Business Overview
11.11.3 Verona Pharma Plc Emphysema Treatment Medication Introduction
11.11.4 Verona Pharma Plc Revenue in Emphysema Treatment Medication Business (2019-2024)
11.11.5 Verona Pharma Plc Recent Development
11.12 GlaxoSmithKline Plc
11.12.1 GlaxoSmithKline Plc Company Details
11.12.2 GlaxoSmithKline Plc Business Overview
11.12.3 GlaxoSmithKline Plc Emphysema Treatment Medication Introduction
11.12.4 GlaxoSmithKline Plc Revenue in Emphysema Treatment Medication Business (2019-2024)
11.12.5 GlaxoSmithKline Plc Recent Development
11.13 Pulmonx
11.13.1 Pulmonx Company Details
11.13.2 Pulmonx Business Overview
11.13.3 Pulmonx Emphysema Treatment Medication Introduction
11.13.4 Pulmonx Revenue in Emphysema Treatment Medication Business (2019-2024)
11.13.5 Pulmonx Recent Development
11.14 Bioxyne
11.14.1 Bioxyne Company Details
11.14.2 Bioxyne Business Overview
11.14.3 Bioxyne Emphysema Treatment Medication Introduction
11.14.4 Bioxyne Revenue in Emphysema Treatment Medication Business (2019-2024)
11.14.5 Bioxyne Recent Development
11.15 Intrexon
11.15.1 Intrexon Company Details
11.15.2 Intrexon Business Overview
11.15.3 Intrexon Emphysema Treatment Medication Introduction
11.15.4 Intrexon Revenue in Emphysema Treatment Medication Business (2019-2024)
11.15.5 Intrexon Recent Development
11.16 Icure Pharmaceuticals
11.16.1 Icure Pharmaceuticals Company Details
11.16.2 Icure Pharmaceuticals Business Overview
11.16.3 Icure Pharmaceuticals Emphysema Treatment Medication Introduction
11.16.4 Icure Pharmaceuticals Revenue in Emphysema Treatment Medication Business (2019-2024)
11.16.5 Icure Pharmaceuticals Recent Development
11.17 Kamada
11.17.1 Kamada Company Details
11.17.2 Kamada Business Overview
11.17.3 Kamada Emphysema Treatment Medication Introduction
11.17.4 Kamada Revenue in Emphysema Treatment Medication Business (2019-2024)
11.17.5 Kamada Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Emphysema Treatment Medication Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Steroids
Table 4. Key Players of Others
Table 5. Global Emphysema Treatment Medication Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Emphysema Treatment Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Emphysema Treatment Medication Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Emphysema Treatment Medication Market Share by Region (2019-2024)
Table 9. Global Emphysema Treatment Medication Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Emphysema Treatment Medication Market Share by Region (2025-2030)
Table 11. Emphysema Treatment Medication Market Trends
Table 12. Emphysema Treatment Medication Market Drivers
Table 13. Emphysema Treatment Medication Market Challenges
Table 14. Emphysema Treatment Medication Market Restraints
Table 15. Global Emphysema Treatment Medication Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Emphysema Treatment Medication Market Share by Players (2019-2024)
Table 17. Global Top Emphysema Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment Medication as of 2023)
Table 18. Ranking of Global Top Emphysema Treatment Medication Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Emphysema Treatment Medication Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Emphysema Treatment Medication, Headquarters and Area Served
Table 21. Global Key Players of Emphysema Treatment Medication, Product and Application
Table 22. Global Key Players of Emphysema Treatment Medication, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Emphysema Treatment Medication Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Emphysema Treatment Medication Revenue Market Share by Type (2019-2024)
Table 26. Global Emphysema Treatment Medication Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Emphysema Treatment Medication Revenue Market Share by Type (2025-2030)
Table 28. Global Emphysema Treatment Medication Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Emphysema Treatment Medication Revenue Market Share by Application (2019-2024)
Table 30. Global Emphysema Treatment Medication Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Emphysema Treatment Medication Revenue Market Share by Application (2025-2030)
Table 32. North America Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Emphysema Treatment Medication Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Emphysema Treatment Medication Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Emphysema Treatment Medication Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Emphysema Treatment Medication Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Emphysema Treatment Medication Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Emphysema Treatment Medication Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Emphysema Treatment Medication Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Emphysema Treatment Medication Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Emphysema Treatment Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Emphysema Treatment Medication Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Emphysema Treatment Medication Market Size by Country (2025-2030) & (US$ Million)
Table 47. Emphasys Medical Company Details
Table 48. Emphasys Medical Business Overview
Table 49. Emphasys Medical Emphysema Treatment Medication Product
Table 50. Emphasys Medical Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 51. Emphasys Medical Recent Development
Table 52. Pfizer Company Details
Table 53. Pfizer Business Overview
Table 54. Pfizer Emphysema Treatment Medication Product
Table 55. Pfizer Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Uptake Medical Company Details
Table 58. Uptake Medical Business Overview
Table 59. Uptake Medical Emphysema Treatment Medication Product
Table 60. Uptake Medical Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 61. Uptake Medical Recent Development
Table 62. Inogen, Inc Company Details
Table 63. Inogen, Inc Business Overview
Table 64. Inogen, Inc Emphysema Treatment Medication Product
Table 65. Inogen, Inc Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 66. Inogen, Inc Recent Development
Table 67. Viatris Inc Company Details
Table 68. Viatris Inc Business Overview
Table 69. Viatris Inc Emphysema Treatment Medication Product
Table 70. Viatris Inc Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 71. Viatris Inc Recent Development
Table 72. Boehringer Ingelheim International GmbH Company Details
Table 73. Boehringer Ingelheim International GmbH Business Overview
Table 74. Boehringer Ingelheim International GmbH Emphysema Treatment Medication Product
Table 75. Boehringer Ingelheim International GmbH Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 76. Boehringer Ingelheim International GmbH Recent Development
Table 77. Novartis AG Company Details
Table 78. Novartis AG Business Overview
Table 79. Novartis AG Emphysema Treatment Medication Product
Table 80. Novartis AG Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 81. Novartis AG Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Emphysema Treatment Medication Product
Table 85. AstraZeneca Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 86. AstraZeneca Recent Development
Table 87. Orion Corporation Company Details
Table 88. Orion Corporation Business Overview
Table 89. Orion Corporation Emphysema Treatment Medication Product
Table 90. Orion Corporation Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 91. Orion Corporation Recent Development
Table 92. Teva Pharmaceutical Industries Ltd Company Details
Table 93. Teva Pharmaceutical Industries Ltd Business Overview
Table 94. Teva Pharmaceutical Industries Ltd Emphysema Treatment Medication Product
Table 95. Teva Pharmaceutical Industries Ltd Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 96. Teva Pharmaceutical Industries Ltd Recent Development
Table 97. Verona Pharma Plc Company Details
Table 98. Verona Pharma Plc Business Overview
Table 99. Verona Pharma Plc Emphysema Treatment Medication Product
Table 100. Verona Pharma Plc Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 101. Verona Pharma Plc Recent Development
Table 102. GlaxoSmithKline Plc Company Details
Table 103. GlaxoSmithKline Plc Business Overview
Table 104. GlaxoSmithKline Plc Emphysema Treatment Medication Product
Table 105. GlaxoSmithKline Plc Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 106. GlaxoSmithKline Plc Recent Development
Table 107. Pulmonx Company Details
Table 108. Pulmonx Business Overview
Table 109. Pulmonx Emphysema Treatment Medication Product
Table 110. Pulmonx Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 111. Pulmonx Recent Development
Table 112. Bioxyne Company Details
Table 113. Bioxyne Business Overview
Table 114. Bioxyne Emphysema Treatment Medication Product
Table 115. Bioxyne Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 116. Bioxyne Recent Development
Table 117. Intrexon Company Details
Table 118. Intrexon Business Overview
Table 119. Intrexon Emphysema Treatment Medication Product
Table 120. Intrexon Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 121. Intrexon Recent Development
Table 122. Icure Pharmaceuticals Company Details
Table 123. Icure Pharmaceuticals Business Overview
Table 124. Icure Pharmaceuticals Emphysema Treatment Medication Product
Table 125. Icure Pharmaceuticals Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 126. Icure Pharmaceuticals Recent Development
Table 127. Kamada Company Details
Table 128. Kamada Business Overview
Table 129. Kamada Emphysema Treatment Medication Product
Table 130. Kamada Revenue in Emphysema Treatment Medication Business (2019-2024) & (US$ Million)
Table 131. Kamada Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
Table 135. Authors List of This Report
List of Figures
Figure 1. Emphysema Treatment Medication Picture
Figure 2. Global Emphysema Treatment Medication Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Emphysema Treatment Medication Market Share by Type: 2023 VS 2030
Figure 4. Bronchodilators Features
Figure 5. Steroids Features
Figure 6. Others Features
Figure 7. Global Emphysema Treatment Medication Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Emphysema Treatment Medication Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Homecare Case Studies
Figure 11. Others Case Studies
Figure 12. Emphysema Treatment Medication Report Years Considered
Figure 13. Global Emphysema Treatment Medication Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Emphysema Treatment Medication Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Emphysema Treatment Medication Market Share by Region: 2023 VS 2030
Figure 16. Global Emphysema Treatment Medication Market Share by Players in 2023
Figure 17. Global Top Emphysema Treatment Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emphysema Treatment Medication as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Emphysema Treatment Medication Revenue in 2023
Figure 19. North America Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Emphysema Treatment Medication Market Share by Country (2019-2030)
Figure 21. United States Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Emphysema Treatment Medication Market Share by Country (2019-2030)
Figure 25. Germany Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Emphysema Treatment Medication Market Share by Region (2019-2030)
Figure 33. China Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Emphysema Treatment Medication Market Share by Country (2019-2030)
Figure 41. Mexico Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Emphysema Treatment Medication Market Share by Country (2019-2030)
Figure 45. Turkey Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE Emphysema Treatment Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Emphasys Medical Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 50. Uptake Medical Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 51. Inogen, Inc Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 52. Viatris Inc Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 53. Boehringer Ingelheim International GmbH Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 54. Novartis AG Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 56. Orion Corporation Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 57. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 58. Verona Pharma Plc Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 59. GlaxoSmithKline Plc Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 60. Pulmonx Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 61. Bioxyne Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 62. Intrexon Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 63. Icure Pharmaceuticals Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 64. Kamada Revenue Growth Rate in Emphysema Treatment Medication Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
